Story perspectives

FDA Approves Updated COVID Vaccines Amid Winter Concerns

9/1/2025

Center

FDA Vaccine Approval

The FDA approved updated COVID-19 vaccines for adults and children, with Moderna and Novavax available for those under 5.
Experts anticipate higher hospitalizations and deaths this winter due to low vaccination rates and misinformation.
The American Academy of Pediatrics recommends vaccinations for children aged 6 months to 18 years due to rising measles cases.
New policies may limit vaccinations to high-risk individuals, affecting access for healthy adults and children.

Right

Kennedy Supports Vaccine Restrictions

CVS and Walgreens are restricting updated COVID-19 vaccine access to seniors and high-risk groups per new FDA guidelines.
CVS has stopped vaccinations in Massachusetts, Nevada, and New Mexico.
Walgreens may require prescriptions for high-risk individuals in certain areas.
Health and Human Services Secretary Robert F. Kennedy Jr. stated these FDA actions support his commitment to end mandates and prioritize vulnerable populations.

Left

FDA Approves COVID Vaccines

The FDA has approved COVID-19 vaccines for individuals aged 65+ and high-risk patients, complicating access for younger individuals.
Health and Human Services Secretary Robert F. Kennedy Jr. has removed COVID-19 vaccines from the immunization schedule for healthy children and pregnant women.
The CDC has not yet issued new vaccine recommendations, leading to uncertainty about insurance coverage.
Major pharmacies like CVS and Walgreens will offer vaccines but may require health condition attestations.
The ACIP will meet on September 18-19 to discuss COVID-19 vaccine recommendations.

1 of 3

FDA Vaccine Approval

The FDA approved updated COVID-19 vaccines for adults and children, with Moderna and Novavax available for those under 5.
Experts anticipate higher hospitalizations and deaths this winter due to low vaccination rates and misinformation.
The American Academy of Pediatrics recommends vaccinations for children aged 6 months to 18 years due to rising measles cases.
New policies may limit vaccinations to high-risk individuals, affecting access for healthy adults and children.

1 / 3